Evaluation of Orthodontic Bands Coated With Nano-silver Fluoride
Evaluation of Antibacterial and Remineralization Effect of Orthodontic Bands Coated With Nano-silver Fluoride: A Randomized Controlled Clinical Trial
-
Aim of the Study To evaluate the antibacterial and enamel remineralization effects of nano-silver fluoride-coated orthodontic bands compared with conventional non-coated bands in orthodontic patients over 6 months.
-
What Will I Do in This Study?
- Conduct a randomized split-mouth clinical trial involving 25 patients.
- Place orthodontic bands on the maxillary first molars, with one band coated and the contralateral band left uncoated as the control.
- Randomize the right or left side receiving the coated band.
- Collect dental plaque samples after 24 hours, 3 months, and 6 months to measure bacterial counts, particularly Streptococcus mutans, using colony-forming unit (CFU) counting.
- Assess enamel demineralization and remineralization using DIAGNOdent measurements before band placement and after band removal.
-
Materials Used
- Orthodontic bands: Stainless steel molar bands.
- Silver nanoparticles (AgNPs): Concentration of 5 µg/mL, with an average particle size of 40 nm.
- Fluoride: Concentration of 5 ppm.
- Coating technique: Dip coating, followed by air-drying and incubator drying.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
-
Background Fixed orthodontic appliances, particularly orthodontic molar bands, contribute significantly to increased plaque retention and bacterial accumulation around the teeth. This heightens the risk of enamel demineralization and the formation of white spot lesions (WSLs). Streptococcus mutans is considered one of the primary etiologic agents in this process, owing to its ability to produce acids that lower plaque pH and initiate enamel demineralization.
Because conventional preventive measures rely heavily on patient compliance and optimal oral hygiene, research has shifted toward developing orthodontic materials with intrinsic antibacterial properties. Nano-Silver Fluoride (NSF)-which combines silver nanoparticles with fluoride-presents a promising agent, as it is expected to reduce bacterial colonization while promoting enamel remineralization. However, clinical evidence evaluating its direct application as a coating on orthodontic molar bands remains limited.
-
Aim of the Study This split-mouth clinical trial aims to evaluate the antibacterial efficacy and enamel remineralization potential of stainless steel orthodontic molar bands coated with Nano-Silver Fluoride compared to uncoated bands during active orthodontic treatment.
-
Interventions This study will be conducted on 25 patients using a split-mouth design, where each patient will receive a coated molar band on one maxillary first molar and an uncoated band on the contralateral maxillary first molar, with side allocation determined through randomization.
Experimental Group: Stainless steel molar bands coated with a Nano-Silver Fluoride solution containing silver nanoparticles (5 µg/mL concentration, 40 nm particle size) and fluoride (5 ppm concentration).
Control Group: Conventional, uncoated stainless steel molar bands.
Coating Method: Dip-coating technique, where the bands are thoroughly cleaned, submerged in the NSF solution for a specified duration, air-dried, and subsequently oven-dried to ensure a stable coating layer.
Assessment of Antibacterial Effect: Plaque samples will be collected from the area surrounding the bands to quantify Streptococcus mutans levels using Colony-Forming Units (CFU) at 24 hours, 3 months, and 6 months.
Assessment of Enamel Remineralization: Changes in white spot lesions and enamel demineralization levels will be measured using DIAGNOdent before band placement and after band removal according to the study's follow-up schedule.
-
Summary / Conclusion This study investigates the feasibility of transforming orthodontic molar bands from passive mechanical retention devices into active preventive components that combine antibacterial activity with the preservation of enamel integrity during orthodontic therapy.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Al Mansurah, Egypt
- Mansoura university
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
-
• Patients presenting with malocclusion, including crowding, spacing, increased overjet or overbite, crossbite, or open bite.
- Presence of a sufficient number of erupted permanent teeth to allow effective placement and retention of orthodontic appliances.
- Good oral and periodontal health, with no active caries or untreated periodontal disease.
- Systemically healthy patients, or those with controlled medical conditions that do not contraindicate orthodontic tooth movement.
- Patients demonstrating adequate motivation and willingness to cooperate, including maintaining oral hygiene and attending regular follow-up visits.
Exclusion Criteria:
-
• Presence of active dental caries or Poor oral hygiene.
- Active periodontal disease, including gingivitis or periodontitis with attachment loss.
- Patients with uncontrolled systemic diseases that may affect bone metabolism or healing (e.g., uncontrolled diabetes, metabolic bone disorders).
- Use of medications that adversely affect orthodontic tooth movement and cannot be medically managed.
- Insufficient erupted teeth to support orthodontic appliances.
- Low motivation or poor compliance, including failure to attend appointments or follow treatment instructions.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Nano-silver Fluoride Coated Orthodontic Bands
Participants receiving orthodontic bands coated with Nano-silver Fluoride (NSF). |
Orthodontic bands coated with Nano-silver Fluoride (NSF) solution applied to cementation to evaluate antibacterial and remineralization effects. |
|
Other: Uncoated Orthodontic Bands
Participants receiving conventional uncoated orthodontic bands. |
Standard uncoated orthodontic bands were used as a control group. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in Streptococcus mutans count in plaque around the band
Time Frame: Baseline, 3 months, and 6 months post-placement.
|
Plaque samples will be collected from around the orthodontic band to quantify Streptococcus mutans levels using Colony Forming Units (CFU/mL) count. |
Baseline, 3 months, and 6 months post-placement.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Remineralization Effect
Time Frame: Baseline, 3 months, and 6 months post-placement.
|
The incidence and severity of white spot lesions on the first molars will be assessed using laser fluorescence (DIAGNOdent). |
Baseline, 3 months, and 6 months post-placement.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- MS.26.02.236
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.